Abstract
Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-catabolizing enzyme that, expressed by different cell types, has regulatory effects on T cells resulting from tryptophan depletion in specific local tissue microenvironments. The discovery that inhibition of IDO activity reduces the survival of MHC-mismatched fetuses in mice and that the risk of fetal allograft rejection correlates with the degree of parental tissue incompatibility has led to the hypothesis that IDO activity protects fetal allografts from maternal T cell-mediated immunity. Different mechanisms, however, might contribute to IDO-dependent immune regulation. We have found that tryptophan metabolites in the kynurenine pathway, such as 3-hydroxyanthranilic and quinolinic acids, will induce the selective apoptosis in vitro of murine thymocytes and Thl but not Th2 cells. T cell apoptosis was observed at relatively low concentrations of kynurenines, did not require Fas/Fas ligand interactions and was associated with the activation of casapase-8 and the release of cytochromecfrom mitochondria. In vivo, the two kynurenines caused depletion of specific thymocyte subsets in a fashion qualitatively similar to dexamethasone. These data may represent the first experimental evidence for the involvement of tryptophan catabolism in the regulation of T cell apoptosis and maintenance of peripheral T cell tolerance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D.H. Munn, M Zhou, J.T. Attwood, I. Bondarev, S.J. Conway, B. Marshall, C. Brown and A.L. Mellor, Prevention of allogeneic fetal rejection by tryptophan catabolismScience 2811191–1193 (1998).
A.L. Mellor, J. Sivakumar, P. Chandler, K. Smith, H. Molina, D. Mao and D.H. Munn, Prevention ofT cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.Nature Immunol. 264–68 (2001).
U. Grohmann, R. Bianchi, M.L. Belladonna, S. Silla, F. Fallarino, M.C. Fioretti and P. Puccetti, IFN-y inhibits presentation of a tumor/self peptide by CD8a-dendritic cells via potentiation of the CD8a+ subsetJ. Immunol. 1651357–1363 (2000).
U. Grohmann, F. Fallarino, R. Bianchi, M.L. Belladonna, C. Vacca, C. Orabona, C. Uyttenhove, M.C. Fioretti and P. Puccetti, L-6 inhibits the tolerogenic function of CD8a+ dendritic cells expressing indoleamine 2,3-dioxygenaseJ. Immunol. 167708–714 (2001).
F. Fallarino, C. Vacca, C. Orabona, M.L. Belladonna, R. Bianchi, B. Marshall, D.B. Kerskin, A.L. Mellor, M.C. Fioretti, U. Grohmann and P. Puccetti, Functional expression of indoleamine 2,3-dioxygenase by murine CD8a+ dendritic cellsInt. /mmunol. 1465–68 (2002).
D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A Pashine and A.L Mellor, Inhibition of T cell proliferation by macrophage tryptophan catabolismJ. Exp. Med. 1891363–1372 (1999).
A.L. Mellor and D.H. Munn, Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?!mmunol. Today 20469–473 (1999).
U. Grohmann and P. Puccetti, The immunosuppressive activity of proinflammatory cytokines in experimental models: potential for therapeutic intervention in autoimmunityCurr. Drug Targets Inflam. Aller. 177–87 (2002).
F. Fallarino, U. Grohmann, R. Bianchi, C. Vacca, M.C. Fioretti and P. Puccetti, Thl and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivoJ. Immunol. 1655495–5501 (2000).
U. Grohmann, R. Bianchi, E. Ayroldi, M.L. Belladonna, D. Surace, M.C. Fioretti and P. Puccetti, A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state.J. Immunol. 1583593–3602 (1997).
T. Shimizu, S. Nomiyama, F. Hirata and O. Hayaishi, lndoleamine 2,3-dioxygenase: purification and some propertiesJ. Biol. Chem. 2534700–4706 (1978).
M.W. Taylor and G. Feng, Relationship between interferon-y, indoleamine 2,3-dioxygenase, and tryptophan catabolismFASEB J. 52516–2522 (1991).
R. Schwarcz, W.O. Whetsell and R.M. Mangano, Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brainScience 219316–318 (1983).
A. Chiarugi, E. Meli and F. Moroni, Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acidJ. Neurochem. 771310–1318 (2001).
T. Morita, K. Saito, M. Takemura, N. Maekawa, S. Fujigaki, H. Fujii, H. Wada, S. Takeuchi, A. Noma and M Seishima, 3-Hydroxyanthranilic acid, an L-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-gammaAnn. Clin. Biochem. 38242–251 (2001).
R.C. Budd, Activation-induced cell deathCurr. Opin. Immunol. 13356–362 (2001).
M. Leist and M. Jaattela, Four deaths and a funeral: from caspases to alternative mechanismsNat. Rev. Mol. Cell. Biol. 2589–598 (2001).
A.C. Foster, L.P. Miller, W.H. Oldendorf and R. Schwarcz, Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the ratExp. Neurot. 84428–440 (1984)
P. Hwu, M.X. Du, R. Lapointe, M. Do, M.W. Taylor and H.A. Young, Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferationJ. Immunol.1643596–3599(2000).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fallarino, F. et al. (2003). T Cell Apoptosis by Kynurenines. In: Allegri, G., Costa, C.V.L., Ragazzi, E., Steinhart, H., Varesio, L. (eds) Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology, vol 527. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0135-0_21
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0135-0_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4939-6
Online ISBN: 978-1-4615-0135-0
eBook Packages: Springer Book Archive